English
Segment disclosures
Company overview인바이츠바이오코아
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
1 dimension combinations 4 retained observations 4 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Consolidated
Consolidated And Separate Financial Statements
Source dimensions
ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 16643930380 | KRW | 20260612 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 12907443606 Restated | KRW | 20260612 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 13307139447 Restated | KRW | 20260612 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 25356985229 | KRW | 20250318 | Open filing evidence |